Strategic Capital Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$4.61M Buy
14,214
+155
+1% +$46.5K 3.81% 4
2022
Q1
$4.03M Sell
14,059
-646
-4% -$166K 3.07% 8
2021
Q4
$4.06M Buy
14,705
+26
+0.2% +$6.59K 2.91% 10
2021
Q3
$3.39M Buy
14,679
+1,085
+8% +$268K 2.64% 11
2021
Q2
$3.12M Sell
13,594
-1,009
-7% -$203K 2.58% 15
2021
Q1
$2.73M Sell
14,603
-3,204
-18% -$627K 2.37% 18
2020
Q4
$3.01M Sell
17,807
-99
-0.6% -$14.8K 2.56% 16
2020
Q3
$2.65M Buy
17,906
+226
+1% +$35K 2.49% 18
2020
Q2
$2.9M Sell
17,680
-1,456
-8% -$223K 2.92% 12
2020
Q1
$2.65M Sell
19,136
-115
-0.6% -$15.8K 3.21% 7
2019
Q4
$2.53M Buy
19,251
+72
+0.4% +$8.35K 2.37% 17
2019
Q3
$2.15M Sell
19,179
-534
-3% -$59.5K 2.39% 20
2019
Q2
$2.18M Buy
19,713
+11,713
+146% +$1.38M 2.3% 20
2019
Q1
$1.04M Sell
8,000
-15,805
-66% -$1.92M 1.12% 35
2018
Q4
$2.75M Sell
23,805
-10,969
-32% -$1.23M 2.96% 8
2018
Q3
$3.73M Buy
34,774
+81
+0.2% +$8.1K 2.66% 12
2018
Q2
$3.36M Buy
34,693
+10,762
+45% +$884K 2.45% 15
2018
Q1
$2.02M Hold
23,931
1.99% 20
2017
Q4
$2.02M Buy
+23,931
New +$2.04M 1.99% 20

Other funds holding LLY

Strategic Capital Advisers's LLY Position: Q2 2022 in Review

Strategic Capital Advisers increased its Eli Lilly (LLY) stake by 1.1% in Q2 2022, buying an estimated $46.5K and bringing the position to 14,214 shares worth $4.61M. The position accounts for 3.81% of the portfolio, ranked #4.

Strategic Capital Advisers first reported a position in LLY in Q4 2017 and has held it in 19 quarters since. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

  • Strategic Capital Advisers held 14,214 shares of Eli Lilly worth $4.61M as of Q2 2022.
  • Strategic Capital Advisers bought 155 Eli Lilly shares in Q2 2022, an estimated $46.5K.
  • Eli Lilly made up 3.81% of Strategic Capital Advisers's portfolio in Q2 2022, its #4 holding.
  • Strategic Capital Advisers first reported a position in Eli Lilly in Q4 2017 and has held it in 19 quarters since.
  • 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on Strategic Capital Advisers's 13F filing for Q2 2022, filed 18 Jul 2022.